Testosterone Esters Compared: Enanthate, Cyp, Nebido, Sus, Test 400

Walk into any gym conversation about gear and the question comes up within five minutes: "what ester are you running?" The answer matters more than most people realise. Testosterone is testosterone, the molecule does the same thing in your body regardless of the ester attached to it. But the ester controls how fast it releases, how often you have to inject, how stable your blood levels are, and how aggressive your side effect profile becomes.

This guide compares every testosterone ester you are likely to encounter, from the propionate that peaks in a day to the undecanoate that lasts three months. It covers TRT-relevant dosing, blast-relevant dosing, and the practical differences that actually change how you run a cycle or maintain a cruise.

What is a testosterone ester?

A testosterone ester is a fatty acid chain attached to the 17-beta hydroxyl group of the testosterone molecule. The ester does two things. First, it makes the molecule more lipophilic ("fat-loving"), which lets it dissolve in the oil vehicle of an injectable preparation and slowly diffuse out of the injection depot. Second, it delays absorption into the bloodstream by holding the molecule at the injection site until enzymes called esterases cleave the bond and release free testosterone.

The longer the carbon chain, the more lipophilic the molecule, the slower it releases. Propionate has a 3-carbon chain and releases in days. Undecanoate has an 11-carbon chain and releases over weeks. Once the ester is cleaved, what enters your circulation is identical regardless of which ester you used. There is no such thing as "stronger" testosterone or "more anabolic" testosterone. The molecule is the same. The release kinetics differ.

This is why milligram-for-milligram comparison between esters can be misleading. 100 mg of testosterone propionate contains roughly 84 mg of pure testosterone (because the propionate ester itself takes up the rest of the weight). 100 mg of testosterone undecanoate contains only about 63 mg of pure testosterone, because the undecanoate ester is heavier. The "per mg of total compound" effective dose is highest for the shortest esters and lowest for the longest (Shoskes et al., 2016).

The complete testosterone ester comparison table

Half-life numbers are approximations from injectable oil-based preparations in adult men. The actual time-to-peak and total clearance varies with injection site, injection volume, body composition, and individual esterase activity.

Short esters: propionate and phenylpropionate

Short esters are the fast-release options. They are the choice when you want quick peaks, quick clearance, or precise control over when testosterone is in your system.

Testosterone propionate

Testosterone propionate is the original injectable testosterone, first marketed in the 1930s. It uses a 3-carbon propionate ester and has a half-life of roughly 19 hours (Shoskes et al., 2016). To maintain stable levels, you need to inject every day or every other day. Most users settle on EOD pinning at 50 to 100 mg per injection.

The pros: rapid action (effects in days, not weeks), short clearance for blood test or competition timing, and milder water retention than longer esters because peak amplitudes are smaller. The cons: daily or near-daily pinning, more injection-site discomfort (propionate is notoriously painful, often called "prop ass" or "test prop pip"), and a much shorter window if you decide to stop. Propionate cycles tend to run 8 to 10 weeks rather than the standard 12 to 16, because the cumulative pin count adds up fast.

Propionate is favoured by bodybuilders heading into a competition or photoshoot, by users running short blasts who want to clear levels before a blood test, and by anyone with poor injection tolerance to longer esters.

Testosterone phenylpropionate

Phenylpropionate sits between propionate and enanthate, with a half-life around 1.5 days. It is rarely sold as a standalone product. You will encounter it mainly as one of the four esters in Sustanon 250 or as a component of underground lab blends. Some 19-nor users will recognise it from nandrolone phenylpropionate (NPP), the short-ester cousin of Deca.

Mid-range esters: enanthate and cypionate

These are the workhorses of both TRT and bodybuilding. Together they account for the overwhelming majority of testosterone prescriptions and underground lab production worldwide.

Testosterone enanthate

Testosterone enanthate has a 7-carbon ester chain and a half-life of approximately 4.5 days. Standard prescribing is once-weekly injection, though twice-weekly (every 3.5 days) gives flatter peak-to-trough kinetics and is preferred by most modern TRT clinics.

Enanthate dominates in Europe, the UK, and Australia (though Australia favours Nebido for full TRT and uses Reandron for the same compound). Common brands include Testoviron Depot, Delatestryl, and a long list of generic preparations from Sun Pharma, Aspen, and others.

For TRT, the standard dose is 100 to 200 mg per week, usually split into two injections. For a blast, the practical range is 400 to 800 mg per week. The Phase 2 pharmacokinetic data shows that 200 mg of intramuscular enanthate produces peak levels around day 4-5 of approximately 1,100 ng/dL, declining to roughly 400 ng/dL by day 14 (Shoskes et al., 2016). This is the wave pattern that makes testosterone draw timing so important on TRT (see our blood test timing on TRT guide for the full protocol).

Testosterone cypionate

Testosterone cypionate has an 8-carbon ester and a half-life of approximately 5 days, almost identical to enanthate. The clinical differences are vanishingly small. Cypionate dominates in the United States, where Depo-Testosterone (Pfizer) and a wide range of generics make up the bulk of TRT prescriptions.

Most users will not feel any practical difference between enanthate and cypionate. The half-life difference is half a day, the injection schedules are the same, the bloodwork looks the same, the side effect profiles are the same. Choose based on what your pharmacy or supplier carries. The "cyp vs enanthate" debate is one of the most overstated arguments in TRT communities.

Long esters: undecanoate (Nebido vs enanthate)

Long esters are designed to reduce injection frequency to once every several weeks. They are almost always the preference for TRT in countries where they are approved, and they are almost never used in cycles.

Testosterone undecanoate (Nebido, Reandron, Aveed)

Testosterone undecanoate in oil has an 11-carbon ester chain and a half-life of around 20 to 21 days. A single 1000 mg injection produces stable supraphysiological levels for the first 1 to 2 weeks, then settles into the upper-normal range and remains there for 10 to 14 weeks before the next dose (Schubert et al., 2004).

This is the preferred TRT formulation in Australia (sold as Reandron 1000), the UK and Europe (Nebido), and is also available in the US as Aveed. It is administered in-clinic in many countries because of the rare but documented risk of pulmonary oil microembolism (POME), where the 4 mL oil bolus reaches pulmonary circulation and causes acute respiratory symptoms. Slow injection over 2 minutes plus 30 minutes of clinical observation is standard protocol.

Nebido vs enanthate: the practical comparison

The most common TRT decision in non-US markets is undecanoate (Nebido or Reandron) versus enanthate. They are very different experiences despite delivering the same molecule.

Choose Nebido or Reandron if: You want fewer injections per year (4 to 5 vs 52+), you have needle anxiety, you have a clinic that handles in-clinic administration, you prefer ultra-stable levels over time, and you do not need to make rapid dose adjustments.

Choose enanthate if: You want to self-inject at home, you want the ability to fine-tune your dose every week or two, you prefer faster steady state (4 to 6 weeks for enanthate vs 20 to 30 weeks for Nebido), or you may transition off TRT in the future and want a faster clearance period.

Bloodwork timing is also fundamentally different. With Nebido, draw blood at the midpoint or trough of the dosing interval (week 8 to 10 of a 10 to 14 week cycle), not at any arbitrary point. Drawing the day after an injection captures peak levels that look alarmingly high relative to reference ranges.

Testosterone decanoate

Decanoate, the 10-carbon ester, has a half-life of around 7 to 10 days. It is not sold as a standalone testosterone product but is the long-acting component of Sustanon 250 and Omnadren, where it provides the trailing release that justifies the "every 2-3 weeks" dosing schedule those products were originally designed for.

Testosterone blends: Sustanon 250, Omnadren, Test 400

Blends combine multiple esters in a single vial. They were originally engineered to provide multi-phase release from one injection, with short esters peaking early and long esters sustaining levels for weeks.

Sustanon 250

Sustanon 250 is the most famous testosterone blend, manufactured by Aspen (formerly Organon). Each millilitre contains:

• 30 mg testosterone propionate
• 60 mg testosterone phenylpropionate
• 60 mg testosterone isocaproate
• 100 mg testosterone decanoate

Total: 250 mg of testosterone esters per mL. Sustanon was designed for once-every-3-weeks dosing for hypogonadal men, but in practice the multi-phase release creates significant blood level fluctuation when used that way. Modern TRT clinics typically prescribe Sustanon at 125 mg twice weekly or 250 mg weekly to maintain stable levels.

For a blast, Sustanon is used like any other testosterone, in the 500 to 750 mg per week range. The short-ester components mean it kicks in within a few days, which some users prefer over waiting 2 to 3 weeks for pure enanthate to peak.

Omnadren

Omnadren is the Polish/Eastern European version of Sustanon, with a slightly different ester ratio. Originally it contained caproate instead of isocaproate (which was reformulated in 2004 to match Sustanon's profile). Functionally, modern Omnadren is essentially equivalent to Sustanon 250.

Test cyp vs Test 400: what is Test 400?

"Test 400" is not a single product. It is a category of underground lab preparations that deliver 400 mg of testosterone esters per millilitre, compared to the standard 200 to 250 mg per mL of pharmaceutical preparations. The ester blend varies by lab but typically combines cypionate, enanthate, and propionate (or sometimes decanoate) to hit the 400 mg/mL target without crystallisation.

The appeal: fewer injections, lower total injection volume for higher-dose blasts. A user running 800 mg per week of test would inject 4 mL of standard 200 mg/mL cypionate but only 2 mL of Test 400. Less oil per injection, less injection-site discomfort over time.

The downsides: Test 400 is not a pharmaceutical product. It comes only from underground labs, so purity and ester ratios are inconsistent batch to batch. The high concentration is achieved with extra carrier oil additives (benzyl benzoate, ethyl oleate) which increase the risk of injection pain, abscess, and allergic reaction. Test 400 also tends to crash out of solution at room temperature, leaving crystals that need to be warmed back into solution before injection.

When Test 400 makes sense vs standard cypionate

Test cyp wins for: TRT, beginner cycles, any user who wants pharmaceutical-grade purity, anyone with sensitive injection sites or seed oil allergies (cypionate is in cottonseed oil, Test 400 carrier oils vary).

Test 400 wins for: High-dose blasts (1+ gram per week) where the injection volume of pharma cypionate becomes impractical, advanced users with good injection technique and well-rotated sites.

For most users the standard answer is straightforward: testosterone cypionate or enanthate at pharmaceutical concentration is the safer, cleaner choice. Test 400 should only be on the table once your weekly dose has scaled past what is comfortable to inject in 2 or 3 mL of standard concentration.

TRT dosing by ester

For replacement-level TRT (targeting mid-normal physiological testosterone, roughly 600 to 900 ng/dL trough), typical doses by ester are:

• Propionate: 75 to 125 mg per week, split into 4 to 7 injections (daily or EOD)
• Enanthate: 100 to 200 mg per week, split into 2 injections (Mon/Thu or similar)
• Cypionate: 100 to 200 mg per week, split into 2 injections (same as enanthate)
• Sustanon 250: 125 mg twice weekly, or 250 mg weekly (avoid the labelled "every 3 weeks" schedule for stable levels)
• Undecanoate (Nebido/Reandron): 1000 mg every 10 to 14 weeks, with a loading dose at week 6 after the first injection

These ranges produce total testosterone in the 500 to 900 ng/dL range for most men (Bhasin et al., 2018). Individual response varies significantly with body composition, age, SHBG, and metabolic rate. Always confirm your protocol with bloodwork at 6 to 8 weeks after starting or changing doses.

Blast and cycle dosing by ester

For a bodybuilding blast, the goal shifts from physiological replacement to supraphysiological levels. Common community ranges (not medical recommendations) are:

• Propionate: 350 to 700 mg per week, EOD or daily
• Enanthate: 400 to 800 mg per week, twice weekly (no benefit to higher doses for most users)
• Cypionate: 400 to 800 mg per week, twice weekly (functionally identical to enanthate)
• Sustanon 250: 500 to 750 mg per week, twice weekly minimum
• Test 400: 800 to 1500 mg per week (only at doses where standard concentration becomes impractical)
• Undecanoate: Not used for blasts. The 20-day half-life makes dose adjustment too slow.

A note on "test undecanoate cycle" searches: there is no practical cycle protocol for Nebido or Reandron. The ester is engineered for TRT replacement, not for cycling. The 3+ month clearance time makes PCT impossible to plan around, and the slow titration means you cannot fine-tune the dose during a cycle. If you are looking at "undecanoate cycle" information, you are almost certainly looking for enanthate or cypionate dosing instead. The decanoate component of Sustanon 250 is the closest a blend gets to "undecanoate-like" duration in a cycle context.

The relationship between dose and effect is non-linear. Doubling your testosterone dose does not double muscle gain or fat loss. Most muscle hypertrophy benefit plateaus around 600 to 800 mg per week of total testosterone equivalent in trained athletes, with diminishing returns above that point (Bhasin et al., 1996). Higher doses primarily amplify side effects, especially erythrocytosis, haematocrit rise, lipid worsening, and prostate symptoms.

How to choose your ester

Use the following decision tree:

1. Are you doing TRT under medical supervision? Follow what your prescriber offers. If you have a choice between Nebido/Reandron and enanthate or cypionate, pick based on injection frequency preference and dose adjustability needs.

2. Are you doing a long blast (12+ weeks) for off-season muscle building? Enanthate or cypionate. Once or twice weekly pinning, predictable kinetics, easy to dose, well-understood side effect profile.

3. Are you doing a short cycle (6-10 weeks) or peaking for a competition? Propionate or a propionate-heavy blend. Faster on-and-off, more control over timing, easier to clear before a target date.

4. Do you want to stack multiple compounds? Match esters where possible. Pair short-ester test (propionate) with short-ester 19-nors (nandrolone phenylpropionate) or short-ester trenbolone (acetate). Pair long-ester test (enanthate, cypionate) with long-ester 19-nors (decanoate) or long-ester trenbolone (enanthate). Matched esters make PCT planning cleaner because everything clears in a similar window.

5. Are you in Australia or the UK with limited prescribing options? Reandron (undecanoate) is the default in Australia, with Sustanon or enanthate as alternatives. UK NHS typically offers Sustanon or Nebido, with private clinics carrying enanthate and cypionate.

Bloodwork implications by ester

Different esters create different blood test patterns. This matters when interpreting your testosterone, estradiol, and haematocrit results.

Short esters produce sharp peaks and rapid troughs. A test drawn 24 hours after injection might read 1,500 ng/dL, while a test 4 days later reads 300 ng/dL. The same protocol, the same week. Trough testing is mandatory, and trough is defined as the morning of your next injection.

Mid-range esters produce moderate peaks. Enanthate or cypionate at 200 mg once weekly peaks at day 4-5 around 1,100 ng/dL and troughs at day 7 around 400 ng/dL. Twice weekly dosing tightens this swing significantly.

Long esters produce the flattest profile. Nebido or Reandron levels stay within a 400 to 800 ng/dL window for most of the dosing interval. The "peak" is wider and lower, the "trough" is closer to the mean.

This affects estradiol aromatisation patterns too. Sharper peaks produce sharper estradiol spikes. Users on short-ester protocols often see estradiol bouncing across reference ranges based on draw timing alone, which is why our estradiol on TRT guide emphasises trough timing over peak timing for E2 decisions.

Haematocrit rise also tracks peak exposure rather than average exposure (Ohlander et al., 2018). Users on short-ester protocols may see higher haematocrit at the same average testosterone level than users on long-ester protocols, simply because the peaks are higher.

Switching between esters

Switching esters is straightforward if you account for the half-life transition.

Short to long (e.g. propionate to enanthate): Inject your last dose of propionate, wait 4 to 5 days, then begin your new enanthate schedule. The propionate is essentially cleared by day 4-5, and enanthate takes 4 to 6 weeks to reach steady state, so there is no overlap concern.

Long to short (e.g. enanthate to propionate): Wait one full half-life of your old ester before starting propionate. For enanthate, that means waiting roughly 7 days after your last injection before starting propionate. Otherwise the residual enanthate stacks on top of propionate peaks and produces unexpectedly high levels in the first week.

Switching to or from Nebido/Reandron: Plan for a long transition. Going from enanthate to Nebido, wait one week after your last enanthate injection, then take your first Nebido dose. Going from Nebido to enanthate, wait 10 to 14 weeks after your last Nebido injection (let levels drop into the lower-normal range) before starting weekly enanthate. Rushing this transition produces double-stacked levels that take months to come back down.

Stacking with peptides and other compounds

For users running testosterone alongside growth hormone secretagogues, the ester choice has no direct interaction with peptides like ipamorelin, CJC-1295, tesamorelin, or MK-677. The peptides do their work independently on the GH/IGF-1 axis. The practical consideration is mainly injection logistics. Daily peptide users on subcutaneous insulin pins find adding a daily or EOD short-ester test (propionate) workflow easy, while longer-ester TRT users tend to keep IM testosterone separate from their daily SubQ peptide schedule.

The marker-level interactions matter more. Adding MK-677 to testosterone increases IGF-1 while potentially worsening fasting glucose and HbA1c. Adding tesamorelin or CJC-1295/ipamorelin can lower visceral fat and improve some metabolic markers. None of this is affected by which testosterone ester you use, but the overall protocol monitoring panel needs to account for the peptide layer regardless of ester choice.

Key takeaways

• All testosterone esters convert to the same free testosterone molecule. The ester only controls release rate, not the underlying effects.
• Short esters (propionate) peak in 1 day and clear in 4-5 days. Mid-range esters (enanthate, cypionate) peak in 4-5 days and clear over 2-3 weeks. Long esters (undecanoate) peak over 1-2 weeks and clear over 3 months.
• Enanthate and cypionate are functionally identical for clinical purposes. Choose based on availability, not pharmacology.
• Nebido (undecanoate) is the dominant TRT preparation in Australia, UK, and Europe. Cypionate dominates in the US. The trade-off is injection frequency versus dose adjustability.
• Sustanon 250 is a four-ester blend designed for less frequent dosing but works better at twice-weekly pinning for stable levels.
• Test 400 is a high-concentration underground blend, useful only at high blast doses where standard concentration becomes impractical to inject.
• For replacement TRT: 100-200 mg/week of enanthate or cypionate, split into two injections.
• For blasts: 400-800 mg/week is the practical sweet spot. Higher doses amplify side effects without proportionally more muscle gain.
• Match ester lengths when stacking with 19-nors or trenbolone for cleaner PCT planning.
• Test undecanoate is not a cycle compound. The half-life is too long for any practical blast or PCT.
• Always confirm protocol changes with bloodwork 6 to 8 weeks after the switch.

---

References

1. Shoskes, J. J., Wilson, M. K., & Spinner, M. L. (2016). Pharmacology of testosterone replacement therapy preparations. Translational Andrology and Urology, 5(6), 834-843. PubMed

2. Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018). Testosterone therapy in men with hypogonadism: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism, 103(5), 1715-1744. PubMed

3. Schubert, M., Minnemann, T., Hübler, D., Rouskova, D., Christoph, A., Oettel, M., Ernst, M., Mellinger, U., Krone, W., & Jockenhövel, F. (2004). Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism. Journal of Clinical Endocrinology & Metabolism, 89(11), 5429-5434. PubMed

4. Ohlander, S. J., Varghese, B., & Pastuszak, A. W. (2018). Erythrocytosis following testosterone therapy. Sexual Medicine Reviews, 6(1), 77-85. PubMed

5. Bhasin, S., Storer, T. W., Berman, N., Callegari, C., Clevenger, B., Phillips, J., Bunnell, T. J., Tricker, R., Shirazi, A., & Casaburi, R. (1996). The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. New England Journal of Medicine, 335(1), 1-7. PubMed